Pre-Exposure Prophylaxis study (treated before exposed to the virus)
et al., medRxiv, doi:10.1101/2020.10.26.20219154 (Preprint)
Clinical Course and Outcomes of coronavirus disease 2019 (COVID-19) in Rheumatic Disease Patients on Immunosuppression: A case Cohort Study at a Single Center with a Significantly Diverse Population
Retrospective hospitalized rheumatic disease patients showing 50% lower mortality for patients on HC
death, ↓50.0%, p=0.67, all patients
death, ↓52.0%, p=0.64, inpatients
Please send us corrections, updates, or comments.